Lixte Biotechnology

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$0
$0
$0
$0
EBITDA
-2,030
-773
-1,574
EBIT
-706
-609
Net Income
-2,030
-775
-709
-617
Net Change In Cash
0
0
0
0
Free Cash Flow
-926
-487
-568
-598
Cash
2,887
887
1,384
1,038
Basic Shares
6,171
2,720
2,471
2,249

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$0
$0
$0
$0
EBITDA
-3,569
-5,070
-6,303
-6,720
EBIT
-3,602
-5,086
-6,312
-6,728
Net Income
-3,585
-5,087
-6,312
-6,728
Net Change In Cash
0
0
0
0
Free Cash Flow
-3,164
-4,293
-4,611
-4,142
Cash
1,038
4,203
5,353
4,823
Basic Shares
2,249
1,915
158
1,347

Earnings Calls

QuarterEPS
2025-09-30
-$0.33
2025-06-30
-$0.29
2025-03-31
-$0.28
2024-12-31
-$0.27